Background
==========

The discrepancy between the amount of livers transplanted annually and patients on the waiting list has been growing over the past decade. In 2009, the waiting list mortality rate was 15% in the United States (approximately 1,500 patients), whereas the transplantation rate was about 38% (5,000 transplantations) \[[@B1]\]. This shortage has driven scientific efforts to increase organ availability targeted at upgrading conventional storage methods (static cold storage (SCS) in University of Wisconsin (UW) solution) or employing graft optimization to allow for extension of donor criteria. First reported in 1967 \[[@B2]\], machine perfusion is a modality whereby organs can be assessed, preserved and treated. In 2009, the first clinical trial with hypothermic machine perfusion (HMP) of human livers was conducted \[[@B3]\]. Besides preserving organs \[[@B4]\], HMP can regenerate ischemic damage and shows potential for reclaiming livers derived from donation after cardiac death (DCD) \[[@B5],[@B6]\]. Although an environment of hypothermia facilitates preservation by slowing cellular metabolism and thereby reducing the need for nutrients and oxygen, the low temperature can cause damage to the microvasculature. Intravital microscopy of hypothermically perfused rat livers has demonstrated that temperature-dependent cellular deformation of sinusoidal endothelial cells obstructs flow, which congests the sinusoid and decreases parenchymal perfusion \[[@B4],[@B7]\]. In addition, the lower temperature decreases the fluidity of the plasma membrane, which can lead to cell lysis and increased enzyme leakage \[[@B8]\]. It follows that because HMP is superior to SCS at temperatures where metabolism is slowed, a separate, perhaps mechanistic phenomenon contributes to this advantage \[[@B9],[@B10]\]. One possibility is that during machine perfusion, harmful waste products are flushed out of the organ and the continuous flow facilitates better availability of the beneficial solution to the peripheral parenchyma of the organ. In addition to HMP, researchers in many studies have explored normothermic machine perfusion (NMP) \[[@B11]-[@B17]\]. Because higher temperature involves increased metabolism, it becomes more essential to promote oxygen delivery, cellular function and bile homeostasis while restricting adverse processes such as nutrient depletion, apoptosis and cellular swelling. Raising the temperature extends both the potential for resuscitation and the risk of organ damage \[[@B11],[@B13],[@B14]\]. Although few studies have compared HMP with NMP in the same setting, NMP has been successful in regenerating warm ischemic grafts and preserving livers in rat and porcine models, proving its superiority over SCS \[[@B17]-[@B24]\].

Studies of machine perfusion have led to the need for additional research, but new trials have been slow to emerge. A potential reason lies in the relative complexity of machine perfusion, which also has hampered its progress when introduced in kidney transplantation \[[@B25],[@B26]\]. A simplified machine perfusion protocol might expedite its implementation, benefiting from the practicality of cold storage while not relinquishing the advantages of machine perfusion. In this context, subnormothermic machine perfusion (SNMP) may offer multiple advantages: no temperature control and a moderate rate of metabolism in which beneficial processes still occur while adverse cellular processes may be controlled.

Coupled with metabolism at the temperatures used in SNMP and NMP is the need for aerobic respiration. Although erythrocytes or artificial oxygen carriers added to the perfusate are effective in delivering oxygen to the liver \[[@B11],[@B18],[@B27],[@B28]\], Vairetti *et al*. successfully used oxygenated SNMP without an oxygen carrier to investigate the temperature-dependence and functional integrity of the graft postperfusion \[[@B29],[@B30]\]. Recently, Gringeri *et al*. applied SNMP without an oxygen carrier to liver grafts for 120 minutes in a porcine model of autotransplantation \[[@B31]\]. Moreover, Tolboom *et al*. calculated the oxygen use of livers during machine perfusion at 20°C and 30°C with an oxygen carrier and concluded that though livers consume more oxygen at 37°C, the addition of the oxygen carrier was not required for adequate liver metabolism at room temperature \[[@B32]\]. Currently, no studies are underway to investigate the validity of SNMP without an oxygen carrier in a long-term transplantation survival model. Moreover, it has not been shown whether, similarly to HMP \[[@B3],[@B8],[@B33]\] and NMP \[[@B13],[@B15],[@B16]\], ischemically damaged organs can be reclaimed and successfully transplanted using this technique.

In this study, we used a SNMP protocol that did not involve dialysis, oxygen carriers or donor pretreatments such as anticoagulants or preconditioning, enabling high-fidelity simulation of DCD. We report herein for the first time that both fresh and warm ischemic livers can be successfully treated by using such a system and transplanted into healthy recipients with good 30-day survival.

Methods
=======

Laboratory animals
------------------

Male Lewis rats weighing 250 to 300 g (Charles River Laboratories, Boston, MA, USA) were used for transplantation. The animals were maintained in accordance with National Research Council guidelines, and the experimental protocols were approved by the Subcommittee on Research Animal Care, Committee on Research, Massachusetts General Hospital (Boston, MA, USA). The animals were divided into four groups: the UW-Control group (*n* = 4, 3 hours at 4°C, SCS preservation and subsequent transplantation), the WI group (*n* = 4, 60 minutes at 34°C, warm ischemia and transplantation), the Fresh-SNMP group (*n* = 6, 3 hours of SNMP and transplantation) and the WI-SNMP group (*n* = 6, 60 minutes at 34°C, warm ischemia followed by 3 hours of SNMP and then transplantation).

Liver procurement (all groups)
------------------------------

All surgical procedures were performed under aseptic conditions. Each animal was weighed and anesthetized with isoflurane (Baxter, Deerfield, IL, USA). The right phrenic vein was ligated, and the liver was freed of its surrounding ligaments. The infrahepatic vena cava (IHVC) was mobilized and elongated by ligation and dissection of the adrenal vein, lumbar plexus and right renal vein. The bile duct was cannulated (SURFLO 28-gauge polyethylene stent; Terumo Medical Corp, Somerset, NJ, USA) and dissected. The portal vein (PV) was mobilized, and its most proximal side vessels (gastroduodenal and splenic veins) were ligated and cut. The hepatic artery was ligated and dissected. The PV and IHVC were cross-clamped, marking the start of ischemic time, and the liver was excised from its recess and weighed. Cuffs fashioned from 16- and 14-gauge intravenous catheters (Becton Dickinson, Franklin Lakes, NJ, USA) were applied to the PV and IHVC as described by Delrivière *et al*. \[[@B34]\]. The suprahepatic vena cava (SHVC) was tailored for a sutured anastomosis.

Static cold storage group
-------------------------

SCS was performed using UW solution (CoStorSol; Preservation Solutions, Inc, Elkhorn, WI, USA). No other preservatives, pharmaceuticals or anticoagulants were used during SCS. Rat livers were procured, prepared for transplantation and cold-stored for 3 hours (matching the established machine perfusion time), then transplanted as described below.

DCD model (WI group and WI-SNMP group)
--------------------------------------

After procurement, the liver was placed without flushing into a chamber filled with saline and maintained at 34.0 ± 0.1°C for 60 minutes. *Ex vivo* warm ischemia has the advantage of temperature control and has been shown to be a relevant and severe model of warm ischemia \[[@B35]\].

Subnormothermic machine perfusion (Fresh-SNMP group and WI-SNMP group)
----------------------------------------------------------------------

Machine perfusion took place in a circuit that consisted of a perfusion chamber, a peristaltic pump, a membrane oxygenator and a bubble trap (Figure [1](#F1){ref-type="fig"}). The liver was perfused through an 18-gauge intravenous catheter (Becton Dickinson) that was connected to the PV cuff. Further details of the perfusion system and technique can be found elsewhere \[[@B36]\]. Temperature within the system was uncontrolled and constantly measured at 21.0°C. The total perfusate volume was 350 ml and consisted of Williams Medium E (Sigma-Aldrich, St Louis, MO, USA) supplemented with insulin (2 U/L Humulin; Eli Lilly & Co, Indianapolis, IN, USA), penicillin (40,000 U/L)/streptomycin (40,000 μg/L) (Gibco/Invitrogen, Camarillo, CA, USA), L-glutamine (0.292 g/L; Gibco/Invitrogen), hydrocortisone (10 mg/L SOLU-CORTEF; Pharmacia & Upjohn/Pfizer, New York, NY, USA) and heparin (1,000 U/L APP pharmaceuticals, Schaumberg, IL, USA). The oxygenator used a mixture of 95% O~2~ and 5% CO~2~, with the CO~2~ serving as a buffering agent, which minimized fluctuation in the perfusate pH (data not shown). Flow rate was started at 8.0 ml/minute and was adjusted according to the portal resistance, which was kept constant between 50 and 100 mM H~2~O. The total perfusion time chosen was 180 minutes, in concurrence with ATP content recovery of the grafts as detailed below, and in an effort to minimize the risk of graft contamination while providing sufficient organ recovery for transplantation.

![Schematic of the subnormothermic machine perfusion system.](2047-1440-1-6-1){#F1}

Perfusate analysis
------------------

Perfusate samples collected every 5 minutes for the first 20 minutes and on the half hour thereafter were tested for alanine aminotransferase (ALT) and aspartate aminotransferase (AST) using Infinity^TM^ ALT(GPT) and AST(GOT) liquid stable reagent kits (Cellomics/Thermo Electron, Pittsburgh, PA, USA). Every 30 minutes PV inflow and inferior vena cava (IHVC) outflow were sampled and analyzed using a Bayer Rapidlab 845 blood gas analyzer (Siemens Medical Solutions, Malvern, PA, USA) to record the partial pressure of oxygen (pO~2~). Those values were used to calculate the oxygen uptake rate (OUR) as detailed previously \[[@B18]\]. Bile was collected, quantified and reentered into the system.

Tissue ATP content
------------------

Livers (*n* = 3 per time point) were flash-frozen in liquid nitrogen directly after procurement (Fresh-SNMP group), after 60 minutes of warm ischemia (WI group/WI-SNMP group) and after 1, 2 and 3 hours of SNMP (Fresh-SNMP group/WI-SNMP group). Various sections (*n* = 7 ± 1) were sampled per liver. Cellular ATP levels were measured using the ApoSENSOR ATP Luminescence Assay Kit (BioVision Inc, Milpitas, CA, USA). The results were normalized for protein content using a Bradford assay (Fisher Scientific, Pittsburgh, PA, USA).

Orthotopic liver transplantation
--------------------------------

Surgery was performed by TB in all cases according to the technique invented by Kamada \[[@B37]\] and described in detail by Delrivière *et al*. \[[@B34]\]. During the final 20 minutes of perfusion, the recipient hepatectomy was carried out up to the start of the anhepatic phase. At the end of machine perfusion, the liver was weighed and flushed with sterile PBS containing 10 U/ml heparin. The recipient hepatectomy was completed, and the donor graft was transplanted, starting with the SHVC anastomosis using a Prolene 7--0 polypropylene suture (Ethicon, Inc, Somerville, NJ, USA). Portal reperfusion occurred 13 to 17 minutes after the start of anhepatic time and approximately 20 to 30 minutes after the end of machine perfusion. Anastomoses of the IVC and bile duct were completed, the animal was administered 1 to 2 ml of sterile PBS intravenously and the abdomen was irrigated with warm PBS and closed. The skin was closed, and the animal was placed under a heat lamp to recover.

Posttransplantation analysis
----------------------------

Blood samples (about 80 μl) were taken from transplantation recipients by way of tail-snip hourly after the procedure for 3 hours, then daily for 7 days after the surgery and finally after 30 days. The blood samples were analyzed using a Piccolo xpress blood chemistry analyzer and a metabolic panel (Abaxis North America, Union City, CA, USA). The animals were inspected regularly for signs of jaundice or infection and were killed 30 days posttransplantation. The liver was mobilized, resected and prepared for histology.

Histology
---------

Livers from each group were sacrificed for histological analysis. Samples were incubated overnight in formalin and embedded in paraffin, then processed and stained with H & E and terminal deoxynucleotidyltransferase 2′-deoxyuridine 5′-triphosphate nick-end labeling (TUNEL). As a negative control for cellular damage, stains derived from fresh liver tissue were used, in comparison to samples from the preserved, treated and transplanted groups. As a positive control for apoptosis, the TUNEL stains from the WI group were used because it has been reported that tissue from warm ischemic liver can exhibit extensive cellular degeneration and apoptosis \[[@B16],[@B38],[@B39]\].

Statistical analysis
--------------------

A paired Student's *t*-test was applied to compare values for each parameter independently. The results were deemed statistically significant if time point comparisons had a *P*-value \<0.05. Statistical significance is indicated in each figure where applicable.

Results
=======

Survival
--------

Survival data are shown in Figure [2](#F2){ref-type="fig"}A. All recipients from the UW-Control and Fresh-SNMP groups survived the 30-day observation period. In the WI-SNMP group, one animal died after approximately 72 hours and the remaining five animals survived the 30-day period. All animals in the WI-only group died within 24 hours after transplantation. Body weight trends are shown in Figure [2](#F2){ref-type="fig"}B. After an initial drop postoperatively, weight gain resumed 7 to 14 days after transplantation in all survivors. Liver recipients in the WI-SNMP group show a significantly delayed recovery in body weight.

![**Follow-up of recipients posttransplantation.(A)** Survival rates of subnormothermically perfused fresh and warm ischemic (WI) livers, as well as the simple cold storage (SCS) control group and the nonperfused WI group. **(B)** Body weights are normalized to preoperative weights. Error bars = SD. \**P* \< 0.05 between WI-SNMP and UW-Control groups. \*\**P* \< 0.05 between WI-SNMP and both the Fresh-SNMP and UW-Control groups.](2047-1440-1-6-2){#F2}

Subnormothermic machine perfusion
---------------------------------

Physiological flow rates in the PV were determined previously at 1.7 to 2.3 ml/minute/g liver \[[@B40]\]. In our system, portal flow rates were based on data from previous experiments \[[@B32],[@B41]\] and ranged from 0.8 to 1.2 ml/minute/g liver. The flow rate was adjusted to the portal pressure, with the objective of keeping the portal pressure constant. The hepatic vascular resistance is expressed as a function of the portal flow and pressure in Figure [3](#F3){ref-type="fig"}. It did not differ significantly between any of the livers, with the exception of one liver (WI-SNMP group) that showed markedly increased vascular resistance throughout perfusion (Figure [3](#F3){ref-type="fig"}). The recipient of this particular liver died on the third day posttransplantation, the only nonsurvivor in the WI-SNMP group.

![**Hepatic resistance (portal pressure/flow rate) during subnormothermic machine perfusion (SNMP) of fresh and warm ischemic groups.** Each line indicates a separate SNMP experiment (*n* = 6 per group).](2047-1440-1-6-3){#F3}

ATP analysis was performed to assess energetic depletion during WI and recovery during SNMP (Figure [4](#F4){ref-type="fig"}). After 60 minutes of warm ischemia, the average ATP content diminished to about 6% of fresh levels. This level was restored after approximately 2.5 hours of SNMP, with ATP values eventually exceeding the fresh ATP level.

![**ATP analysis of fresh, warm ischemic and subnormothermically perfused livers.** Error bars = 95% CI.](2047-1440-1-6-4){#F4}

During SNMP, the perfusate was analyzed for hepatocyte damage indicators. Figures [5](#F5){ref-type="fig"}A and [5](#F5){ref-type="fig"}B show cumulative levels of ALT and AST. The levels of ALT, but not of AST, were consistently higher in the WI-SNMP group. Because these data are cumulative, the horizontal trend in the graph indicates stabilization of transaminase output in the perfusate.

![**Parameters studied during subnormothermic machine perfusion of fresh and warm ischemic livers.** Subnormothermic machine perfusion of fresh and warm ischemic (WI) livers showing levels of alanine aminotransferase **(A)**, aspartate aminotransferase **(B)**, oxygen uptake **(C)** and bile production **(D)**. The *in situ* bars represent 30 minutes of bile collection *in situ* (in the 1-hour WI group, this collection predates the WI treatment). Error bars = SD. ^\*^*P* \< 0.05 between fresh and WI groups.](2047-1440-1-6-5){#F5}

The pO~2~ in the perfusate was used to calculate the OUR (Figure [5](#F5){ref-type="fig"}C). The OUR was stable during SNMP, without differences between the groups. The pO~2~ in the outflow remained above 200 mmHg, indicating that the pO~2~ in the inflow perfusate was sufficient for hepatic oxygenation.

As a determinant of synthetic function, bile production is a prerequisite for successful transplantation \[[@B42]\]. *In vivo* bile flow ranges from 15 to 20 μl/g liver in healthy rats. During SNMP, bile flow averaged about 10 μl/g liver. It seems likely that the lower bile flow is due to the lower temperature during SNMP. Bile production was not significantly higher in the Fresh-SNMP group than in the WI-SNMP group (Figure [5](#F5){ref-type="fig"}D).

Posttransplantation blood analysis
----------------------------------

Blood work was performed hourly for the first 3 hours, then daily for 7 days and finally 30 days after transplantation. The most relevant parameters include serum transaminases (ALT and AST), total bilirubin (TB) and blood urea nitrogen (BUN) (Figure [6](#F6){ref-type="fig"}). In the 3 hours following reperfusion, transaminases spiked, most prominently in the WI-SNMP group (Figures [6](#F6){ref-type="fig"}A and [6](#F6){ref-type="fig"}B). Over the next 7 days, ALT levels were significantly higher in the WI-SNMP group, whereas the ALT levels in the Fresh-SNMP and UW-Control groups remained slightly elevated. Levels of AST were higher in both the WI-SNMP and Fresh-SNMP groups compared to the UW-Control group. In the WI group, the levels of ALT and AST climbed until death within the first 24 hours after surgery (Figures [6](#F6){ref-type="fig"}A and [6](#F6){ref-type="fig"}B). The nonsurviving animal in the WI-SNMP group displayed rapidly increasing levels of both AST and ALT, with readings at *t* = 72 hours in excess of 1,000 U/L. Among the surviving animals in all groups, the levels of AST and ALT were within normal range (\<80 U/L) after the 30-day period.

![**Blood results post-transplantation included alanine aminotransferase (A), aspartate aminotransferase (B), total bilirubin (C) and blood urea nitrogen (D).** Error bars = SEM. \**P* \< 0.05 between the WI-SNMP group and both the Fresh-SNMP and UW-Control groups.](2047-1440-1-6-6){#F6}

TB increased mildly over the first 7 days, which was more apparent in the Fresh-SNMP group (Figure [6](#F6){ref-type="fig"}C). At the end of the 30-day period, TB was increased to approximately 2 mg/dl in all surviving animals. BUN levels were stable during the postoperative phase and throughout the 30-day period (Figure [6](#F6){ref-type="fig"}D).

Histological analysis (H & E and TUNEL staining) of livers pre- and posttransplantation is displayed in Figure [7](#F7){ref-type="fig"}. Although a few apoptotic cells were seen in all of the samples, including fresh liver (Figure [7](#F7){ref-type="fig"}A), there were no signs of necrosis or cellular swelling, with the exception of the WI group (Figure [7](#F7){ref-type="fig"}B). Pyknotic cells were observed throughout this sample, indicating cellular degeneration. After 3 hours of SNMP (WI-SNMP group) (Figure [7](#F7){ref-type="fig"}C), this finding disappeared, so that the tissue histomorphologically resembled fresh liver tissue. At 30 days posttransplantation, all groups showed normal hepatocellular architecture and microvasculature (Figures [7](#F7){ref-type="fig"}D to [7](#F7){ref-type="fig"}F). Hyperplasia of biliary epithelium was observed in all transplanted livers, inherent to this model, which uses a stent for the bile duct anastomosis.

![**Histological appearance of liver grafts pre- and posttransplantation (H & E staining and terminal deoxynucleotidyltransferase 2′-deoxyuridine 5′-triphosphate nick-end labeling (TUNEL) staining, respectively).** Top: sections from fresh liver, University of Wisconsin (UW) solution group and WI-SNMP groups. Bottom: 30 days posttransplantation autopsic resections from all survivors (UW-Control group, Fresh-SNMP and WI-SNMP groups).](2047-1440-1-6-7){#F7}

Discussion
==========

SCS is practical and cost-effective but does not allow the resuscitation of damaged grafts, which is vital to the extended incorporation of marginal organs \[[@B43]\]. In addition, evaluation of organ quality during SCS is limited to subjective assessments. To combine the simplicity of SCS with the therapeutic impact of machine perfusion, we established a practical SNMP system that requires no temperature control, donor blood or artificial oxygen carriers. In an analogous study by our group, this system was used to optimize livers for hepatocyte isolation (ML Izamis, personal communication). Herein we have shown that fresh livers could be preserved for 3 hours and transplanted successfully, with survival rates and secondary outcomes equivalent to conventional cold storage parameters. Furthermore, we used this system to treat livers with sustained warm ischemia, which were then successfully transplanted.

In the animal from the WI-SNMP group that died within 72 hours after transplantation, the highly elevated levels of AST and ALT point to primary nonfunction. During treatment, the portal pressure of this liver was significantly increased, suggesting a correlation between high vascular resistance and graft failure. Although this is a singular finding in our study, the principle of vascular resistance as a predictor of graft viability has been suggested elsewhere \[[@B44]\]. We conclude that high vascular resistance during machine perfusion could serve as a warning sign indicative of a mechanical or physiological problem. However, specific research into this phenomenon should be continued on a broad scale.

Cumulative ALT levels during SNMP were highest in the WI-SNMP group. After 1 hour of SNMP, these levels reached a plateau, signifying that the hepatocyte damage caused by the WI period had been contained. Warm ischemic and fresh livers consumed similar amounts of oxygen during the SNMP period. We observed that oxygen consumption rates were not affected by the organ's condition. We can conclude that resuscitation of a warm ischemic liver to a transplantable state does not require more oxygen than the SNMP preservation of a fresh liver. In addition, the high residual oxygen content in the outflow perfusate indicates that none of the livers exhausted the supply of oxygen. Moreover, the ATP recovery of warm ischemic livers beyond fresh levels also points to adequate aerobic respiration in the ischemic grafts. Thus we conclude that our system did not require an oxygen carrier.

The WI-SNMP group showed higher levels of transaminase leakage posttransplantation, indicating that although the livers were reclaimed adequately for recipient survival, there was still regenerative potential that remained unfulfilled. These observations are concurrent with the body weight trends: animals in all groups initially lost weight, but the UW-Control and Fresh-SNMP groups regained that weight sooner than the WI-SNMP group. Possibly, SNMP was responsible for only part of the restoration process and the remainder was carried out at the expense of the recipient. Another explanation may be that certain specific effects of warm ischemia were not mitigated by the SNMP and could be only restored by the recipients themselves, which in this case were young and healthy animals. As rats have great regenerative capacity, this phenomenon may be of greater consequence in a higher-order species. Although patients with end-stage liver disease are often in a fragile physical state, it has been shown that human livers from patients with elevated transaminases \[[@B45]\] or sustained warm ischemia \[[@B46]\] can be successfully transplanted. Whether our findings call for a longer or enhanced SNMP period will be clarified by continued investigation.

Conclusion
==========

In this study, we have established a protocol for SNMP, without oxygen carriers and without temperature control, that uses oxygenated and supplemented cell culture medium as perfusate. We applied this system to demonstrate feasibility against the current gold standard for the preservation of fresh organs, as well as the potential for regeneration of DCD grafts.
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